Recall Register

Food, drugs, devices › Siemens Healthcare Diagnostics, Inc.

Device recall: Atellica IM 1300 Analyzer - automated, immunoassay analyzer designed to perform in vitro diagnostic tests on clinical sp

FDA enforcement event 90153 · Class II · initiated 13 Apr 2022 · status Ongoing

DeviceVoluntary: Firm initiated2 product recordsTarrytown, NY

FDA enforcement event 90153 is a device recall by Siemens Healthcare Diagnostics, Inc. of Tarrytown, NY, initiated 13 Apr 2022 and classified Class II, with 2 product records.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 839 device enforcement events initiated in 2022 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Siemens Healthcare Diagnostics, Inc. has 333 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Siemens Healthcare Diagnostics, Inc., Tarrytown, NY.

Reason for recall

"Lots incompatible with Test Definition (TDef) Version 1.4, potentially lead to the generation of erroneous total T3 results"

Distribution

"Worldwide distribution - US Nationwide and the countries of Albania, Argentina, Austria, Bahamas, Bangladesh, Belgium, Brazil, Chile, China, Columbia, Croatia, Czech¿Republic, Denmark, Ecuador,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1252-2022Atellica IM 1300 Analyzer - automated, immunoassay analyzer designed to perform in vitro diagnostic tests on clinical specimens. Siemens Material Number (SMN): 110660011,566Class IIOngoing15 Jun 2022
Z-1253-2022Atellica IM 1600 Analyzer - automated, immunoassay analyzer designed to perform in vitro diagnostic tests on clinical specimens Siemens Material Number (SMN): 110660002,321Class IIOngoing15 Jun 2022

Context

88%of 2022 device events are Class II839 events that year
2product records in this eventfirm median: 1
333events on this register for the firm

Other enforcement events for Siemens Healthcare Diagnostics, Inc.

InitiatedProduct (first record)TypeClassRecords
13 Jul 2026Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLDeviceClass II2
6 Jul 2026Atellica CH Urine Albumin REF: 11537225, in vitro diagnosticDeviceClass II1
26 Jun 2026Syva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULDeviceClass III1
26 Jun 2026Syva Emit Disopyramide Assay Enzyme Immunoassay, Lidocaine SMN 10445370 Catalog No 6N319ULDeviceClass III1
8 Jun 2026Atellica CH Enzymatic Hemoglobin A1c (A1c_E). Material Number: 11097536.DeviceClass II1
7 May 2026Siemens Dimension Tacrolimus Flex Reagent Cartridge (TAC), REF DF207, SMN 10700795; enzyme immunoassayDeviceClass II1
2 Apr 2026epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System; Siemens Material Number (SMN): 10736515;DeviceClass II1
18 Mar 2026Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.DeviceClass II1
23 Feb 2026Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536;DeviceClass II1
20 Jan 2026Atellica CH Urine Albumin (UAlb). Material Number: 11537225DeviceClass II1

All 333 events for Siemens Healthcare Diagnostics, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Lots incompatible with Test Definition (TDef) Version 1.4, potentially lead to the generation of erroneous total T3 results"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide and the countries of Albania, Argentina, Austria, Bahamas, Bangladesh, Belgium, Brazil, Chile, China, Columbia, Croatia, Czech¿Republic, Denmark, Ecuador,…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.